Who has invested in Adendra Therapeutics?

Apple Tree Partners are named among the investors backing Adendra Therapeutics.

Adendra Therapeutics Funding: $53M Raised, Series A (2021)

Adendra Therapeutics funding overview

Adendra Therapeutics is based in Potters Bar, United Kingdom. Adendra Therapeutics has raised $53M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for Adendra Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Apple Tree Partners.

Adendra Therapeutics at a glance

Total raised: $53M
Latest round: Series A
Latest round date: December 2021
Headquarters: Potters Bar, United Kingdom
Notable investors: Apple Tree Partners

Frequently asked about Adendra Therapeutics funding

How much has Adendra Therapeutics raised?: Adendra Therapeutics has raised $53M in total disclosed funding across the rounds on record.
Who has invested in Adendra Therapeutics?: Apple Tree Partners are named among the investors backing Adendra Therapeutics.
What was the latest Adendra Therapeutics funding round?: The most recent disclosed round is a Series A, announced in December 2021.
Where is Adendra Therapeutics based?: Adendra Therapeutics is based in Potters Bar, United Kingdom.
When did Adendra Therapeutics last raise?: The last disclosed Adendra Therapeutics round closed in December 2021 at Series A.

Adendra Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Potters Bar below to benchmark round size and investor mix.

Adendra Therapeutics Funding: $53M Raised, Series A (2021)

Adendra Therapeutics funding overview

Adendra Therapeutics at a glance

Frequently asked about Adendra Therapeutics funding

Companies related to Adendra Therapeutics (14)

Browse related funding lists (4)